Samuel Pine
Director
Bioanalytical
BioAgilytix
Germany
Biography
Dr. Pine is an accomplished immunologist with an extensive background supporting biotherapeutic, vaccine, and immunodiagnostic projects from discovery through post-marketing. Prior to joining BioAgilytix, Dr. Pine was AssociateDirector of Non-Clinical and Translational Sciences at Allergan, where he worked closely with drug safety scientists to develop novel protein therapeutics for ocular, neurologic, urologic, and dermatologic indications. He also garnered experience developing vaccines for a variety of infectious diseases through his previous positions with the Infectious Disease Research Institute, the HIV Vaccine Trial Network/Fred Hutchinson Cancer Research Center, and Novartis. Today Dr. Pine holds a patent as the co-inventor of “Composition and methods for stimulating an immune response against infectious agents”, has been published in numerous scientific journals, and actively contributes his insight to regulatory submission documents and peer-reviewed manuscripts.Dr. Pine received his BA in Molecular, Cellular and Developmental Biology from the University of California at Santa Cruz, and his Ph.D. from the University of Washington, Department of Global Health.
Research Interest
Ocular, Neurologic, Urologic, and Dermatologic indication
